Air classifier technology (ACT) in dry powder inhalation - Part I. Introduction of a novel force distribution concept (FDC) explaining the performance of a basic air classifier on adhesive mixtures

被引:90
作者
de Boer, AH
Hagedoorn, P
Gjaltema, D
Goede, J
Frijlink, HW
机构
[1] Univ Groningen, GUIDE, Dept Pharmaceut Technol & Biopharm, NL-9713 AV Groningen, Netherlands
[2] Sofotec GmbH & Co KG, D-60314 Frankfurt, Germany
关键词
dry powder inhalation; air classifier technology; adhesive mixtures; powder dispersion; force distribution concept; carrier retention;
D O I
10.1016/S0378-5173(03)00250-3
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Air classifier technology (ACT) is introduced as part of formulation integrated dry powder inhaler development (FIDPI) to optimise the de-agglomeration of inhalation powders. Carrier retention and de-agglomeration results obtained with a basic classifier concept are discussed. The theoretical cut-off diameter for lactose of the classifier used, is between 35 and 15 mum for flow rates ranging from 20 to 70 l/min. Carrier retention of narrow size fractions is higher than 80% for flow rates between 30 and 60 l/min, inhalation times up to 6 s and classifier payloads between 0 and 30 mg. The de-agglomeration efficiency for adhesive mixtures, derived from carrier residue (CR) measurement, increases both with increasing flow rate and inhalation time. At 30 l/min, 60% fine particle detachment can be obtained within 3 s circulation time, whereas at 60 l/min only 0.5 s is necessary to release more than 70%. More detailed information of the change of detachment rate within the first 0.5 s of inhalation is obtained from laser diffraction analysis (LDA) of the aerosol cloud. The experimental results can be explained with a novel force distribution concept (FDC) which is introduced to better understand the complex effects of mixing and inhalation parameters on the size distributions of adhesion and removal forces and their relevance to the de-agglomeration in the classifier. (C) 2003 Elsevier B.V. All rights reserved.
引用
收藏
页码:187 / 200
页数:14
相关论文
共 26 条
[1]  
[Anonymous], PHARMEUROPA
[2]  
ARNOLD K, 1993, Patent No. 0663815
[3]  
BEGAT P, 2001, P DRUG DELIVERY LUNG, V12, P119
[4]   DRY POWDER AEROSOLS .1. NEW POWDER INHALATION DEVICE [J].
BELL, JH ;
HARTLEY, PS ;
COX, JSG .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1971, 60 (10) :1559-&
[5]   Design and application of a new modular adapter for laser diffraction characterization of inhalation aerosols [J].
de Boer, AH ;
Gjaltema, D ;
Hagedoorn, P ;
Schaller, M ;
Witt, W ;
Frijlink, HW .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2002, 249 (1-2) :233-245
[6]  
DEBOER AH, 2002, P DRUG DELIVERY LUNG, V13, P7
[7]   The effect of budesonide particle mass on drug particle detachment from carrier crystals in adhesive mixtures during inhalation [J].
Dickhoff, BHJ ;
Ellison, MJH ;
de Boer, AH ;
Frijlink, HW .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2002, 54 (02) :245-248
[8]  
GANDERTON D, 1991, Patent No. 9111179
[9]   SIZE ANALYSIS OF SUSPENSION INHALATION AEROSOLS BY INERTIAL SEPARATION METHODS [J].
HALLWORTH, GW ;
ANDREWS, UG .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1976, 28 (12) :898-907
[10]   Investigation of powder dispersion inside a SPIROS® dry dry powder inhaler using particle image velocimetry [J].
Han, R ;
Papadopoulos, G ;
Greenspan, BJ .
POWDER TECHNOLOGY, 2002, 125 (2-3) :266-278